TITLE

Voxel-Based Correlation between Coregistered Single-Photon Emission Computed Tomography and Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Subjects with Suspected Alzheimer Disease

AUTHOR(S)
Cavallin, L.; Axelsson, R.; Wahlund, L. O.; Oksengard, A. R.; Svensson, L.; Juhlin, P.; Wiberg, M. Kristoffersen; Frank, A.
PUB. DATE
December 2008
SOURCE
Acta Radiologica;Dec2008, Vol. 49 Issue 10, p1154
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Current diagnosis of Alzheimer disease is made by clinical, neuropsychologic, and neuroimaging assessments. Neuroimaging techniques such as magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT) could be valuable in the differential diagnosis of Alzheimer disease, as well as in assessing prognosis. Purpose: To compare SPECT and MRI in a cohort of patients examined for suspected dementia, including patients with no objective cognitive impairment (control group), mild cognitive impairment (MCI), and Alzheimer disease (AD). Material and Methods: 24 patients, eight with AD, 10 with MCI, and six controls, were investigated with SPECT using 99mTc-hexamethylpropyleneamine oxime (HMPAO, Ceretec; GE Healthcare Ltd., Little Chalsont UK) and dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) with a contrast-enhancing gadobutrol formula (Gadovist; Bayer Schering Pharma, Berlin, Germany). Voxel-based correlation between coregistered SPECT and DSC-MR images was calculated. Region-of-interest (ROI) analyses were then performed in 24 different brain areas using brain registration and analysis of SPECT studies (BRASS; Nuclear Diagnostics AB, Stockholm, Sweden) on both SPECT and DSC-MRI. Results: Voxel-based correlation between coregistered SPECT and DSC-MR showed a high correlation, with a mean correlation coefficient of 0.94. ROI analyses of 24 regions showed significant differences between the control group and AD patients in 10 regions using SPECT and five regions in DSC-MR. Conclusion: SPECT remains superior to DSC-MRI in differentiating normal from pathological perfusion, and DSC-MRI could not replace SPECT in the diagnosis of patients with Alzheimer disease.
ACCESSION #
35383902

 

Related Articles

  • Can Dynamic Susceptibility Contrast Magnetic Resonance Imaging Replace Single‐Photon Emission Computed Tomography in the Diagnosis of Patients with Alzheimer's Disease? A Pilot Study. Cavallin, L.; Danielsson, R.; Öksengard, A. R.; Wahlund, L. O.; Julin, P.; Frank, A.; Engman, E. L.; Svensson, L.; Wiberg, Kristoffersen M. // Acta Radiologica;Nov2006, Vol. 47 Issue 9, p977 

    Purpose: To compare single‐photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) in a cohort of patients examined for suspected dementia, including patients with no objective cognitive impairment (control group), mild cognitive impairment (MCI), and Alzheimer's...

  • Imaging Alzheimer in 2011. Hazewinkel, Marieke; Barkhof, Frederik // Neuroradiology;Sep2011, Vol. 53, p145 

    The article focuses on the use of diagnostic imaging in Alzheimer's Dementia (AD). Both magnetic resonance imaging (MRI) and computed tomography are sensitive enough to show medial temporal lobe atrophy and parietal atrophy. The proteins associated with AD, amyloid-beta and hyper-phosphorylated...

  • Understanding Alzheimer's Disease: The pros and cons of available diagnostic imaging. Nixon, Marie // Synergy: Imaging & Therapy Practice;Jan2014, p27 

    The article discusses the gaps and controversies on existing knowledge about Alzheimer's disease and examines the diagnostic imaging available for its diagnosis. Topics discussed include an overview of the history of the disease, diagnostic methods, common risk factors. Also mentioned are the...

  • Suspected early dementia. Schott, Jonathan M.; Warren, Jason D.; Barkhof, Frederik; Rossor, Martin N.; Fox, Nick C. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/24/2011, Vol. 343 Issue 7824, p634 

    The article discusses how imaging can be used to investigate a patient with suspected early dementia. Anxiety and depression are associated with cognitive symptoms and they also complicate established dementia. It is suggested that all patients with cognitive impairment undergo structural...

  • Evaluation of magnetic resonance imaging-negative drug-resistant epilepsy. Shah, Aashit K.; Mittal, Sandeep // Annals of Indian Academy of Neurology;Mar2014 Supplement 1, Vol. 17 Issue S1, pS80 

    A structural brain lesion in patients with drug-resistant epilepsy (DRE) greatly increases the likelihood of identification of the seizure focus and ultimately seizure-free outcome following resective epilepsy surgery. In contrast, surgical outcomes of true non-lesional DRE are less favorable....

  • Asperger Syndrome with Highly Exceptional Calendar Memory: A Case Report.  // Turkish Journal of Psychiatry;Fall2010, Vol. 21 Issue 3, p1 

    No abstract available.

  • Arterial Spin Labeling Perfusion MRI in Alzheimer's Disease. van Osch, Matthias J.P.; Lu, Hanzhang // Current Medical Imaging Reviews;Feb2011, Vol. 7 Issue 1, p62 

    Although nuclear medicine imaging methods such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) were the first to show a distinctive pattern of hypometabolism and hypoperfusion in patients with Alzheimer's disease (AD), large-scale application of these...

  • [18F]FDG-PET as a Biomarker for Early Alzheimer's Disease. Nobili, Flavio; Morbelli, Silvia // Open Nuclear Medicine Journal;2010 Special Issue, p46 

    [18Fluorine]fluorodeoxiglucose-Positron Emission Tomgraphy (18F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complaints, notably Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Together with morphological Magnetic Resonance Imaging...

  • PS May Reverse Early Brain Decline.  // Total Health;Nov2005, Vol. 27 Issue 4, p11 

    The section discusses the role of PhosphatidylSerine in revitalizing the declining brain. Brain decline that noticeably interferes with productivity and personal independence is not a normal feature of aging. A degree of brain decline abnormal for one's age group indicates increased risk for...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics